SGLT2 is not expressed in hepatocytes and its effects were attributed to reduced blood glucose levels and the subsequent amelioration of insulin resistance, which might have altered the expressions of genes regulating hepatic lipid metabolism. This evidence concerns the gene SLC5A2 and Insulin resistance.